Inmed Pharmaceuticals

IN-T

Analysis and Opinions about IN-T

Signal
Opinion
Expert
SPECULATIVE BUY
SPECULATIVE BUY
May 15, 2018

This is another company in the cannabis space. This is not a cannabis producer, it is a company that adds value in that space. They are mapping cannabinoids, looking for different formulations to treat different diseases.It is highly speculative, but he thinks there is opportunity for this type of company. He likes the management. In a growth market, as the US opens up, this could do very well. He owns stocks like this in a basket. He is not betting on any one of them; instead he is expecting the overall basket to do well.

Show full opinionHide full opinion

This is another company in the cannabis space. This is not a cannabis producer, it is a company that adds value in that space. They are mapping cannabinoids, looking for different formulations to treat different diseases.It is highly speculative, but he thinks there is opportunity for this type of company. He likes the management. In a growth market, as the US opens up, this could do very well. He owns stocks like this in a basket. He is not betting on any one of them; instead he is expecting the overall basket to do well.

Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Inmed Pharmaceuticals(IN-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Inmed Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Inmed Pharmaceuticals(IN-T) Frequently Asked Questions

What is Inmed Pharmaceuticals stock symbol?

Inmed Pharmaceuticals is a Canadian stock, trading under the symbol IN-T on the Toronto Stock Exchange (IN-CT). It is usually referred to as TSX:IN or IN-T

Is Inmed Pharmaceuticals a buy or a sell?

In the last year, there was no coverage of Inmed Pharmaceuticals published on Stockchase.

Is Inmed Pharmaceuticals a good investment or a top pick?

Inmed Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Inmed Pharmaceuticals.

Why is Inmed Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Inmed Pharmaceuticals worth watching?

In the last year, there was no coverage of Inmed Pharmaceuticals published on Stockchase.

What is Inmed Pharmaceuticals stock price?

On 2020-02-26, Inmed Pharmaceuticals (IN-T) stock closed at a price of $0.36.